Keyphrases
Treatment Response
100%
Pathologic
100%
Rectal Adenocarcinoma
100%
Neoadjuvant
100%
Neoadjuvant Therapy
66%
Overall Survival
50%
Pathological Complete Response
50%
C-X-C Chemokine Receptor Type 4 (CXCR4)
50%
Pretreatment Biopsy
50%
Residual Tumor
33%
College of American Pathologists
33%
Overexpression
16%
Resection
16%
Pathological Features
16%
Resection Specimen
16%
Tumor Differentiation
16%
Immunohistochemical Analysis
16%
Partial Response
16%
Clinical Factors
16%
Surgical Resection
16%
Response Group
16%
Recurrence-free Survival
16%
Long Interval
16%
Stage Group
16%
Tumor-infiltrating Lymphocytes
16%
No Response
16%
Nuclear Expression
16%
Treatment Standards
16%
Pathologic Factors
16%
Transanal Total Mesorectal Excision (taTME)
16%
Diagnostic Biopsy
16%
CEA Levels
16%
Medicine and Dentistry
Treatment Response
100%
Rectum Carcinoma
100%
Biopsy
66%
Neoadjuvant Therapy
66%
Surgery
50%
Overall Survival
50%
Neoplasm
33%
Pathologist
33%
Diagnosis
16%
Tumor Differentiation
16%
Carcinoembryonic Antigen
16%
Chemokine Receptor
16%
Recurrence Free Survival
16%
Tumor Infiltrating Lymphocyte
16%
Total Mesorectal Excision
16%